Gene: SIAH2
Official Full Name: siah E3 ubiquitin protein ligase 2provided by HGNC
Gene Summary: This gene encodes a protein that is a member of the seven in absentia homolog (SIAH) family. The protein is an E3 ligase and is involved in ubiquitination and proteasome-mediated degradation of specific proteins. The activity of this ubiquitin ligase has been implicated in regulating cellular response to hypoxia. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07051 | SIAH2 Knockout cell line (HeLa) | Human | SIAH2 | 1:3~1:6 | Negative | Online Inquiry |
KO07052 | SIAH2 Knockout cell line (HCT 116) | Human | SIAH2 | 1:2~1:4 | Negative | Online Inquiry |
KO07053 | SIAH2 Knockout cell line (HEK293) | Human | SIAH2 | 1:3~1:6 | Negative | Online Inquiry |
KO07054 | SIAH2 Knockout cell line (A549) | Human | SIAH2 | 1:3~1:4 | Negative | Online Inquiry |
SIAH2 Gene Knockout Cell Lines are genetically modified cellular models designed to specifically eliminate the expression of the SIAH2 gene, which encodes for the Seven In Absentia Homolog 2 protein, a critical regulator of various cellular processes, including apoptosis, cell cycle progression, and oncogenic signaling pathways. By utilizing CRISPR-Cas9 technology or similar gene-editing techniques, these cell lines offer researchers a robust tool for elucidating the functional role of SIAH2 in health and disease.
The primary mechanism by which SIAH2 Gene Knockout Cell Lines operate is through the targeted disruption of the SIAH2 gene. This results in the loss of its protein product, allowing for the detailed study of downstream effects on signaling pathways associated with tumor suppression, neurodegeneration, and cellular response to stress. Researchers can leverage these knockout models to investigate the role of SIAH2 in various biological contexts, making them invaluable for cancer research, drug discovery, and the development of therapeutic strategies.
The scientific importance of these cell lines lies in their ability to serve as a reference point for understanding aberrant SIAH2 signaling in pathological conditions. Their applications extend to both fundamental research and clinical settings, where elucidating the role of SIAH2 can lead to novel biomarkers for cancer prognosis or new drug targets. Unlike traditional methods that involve overexpression or the use of small interfering RNA (siRNA), our gene knockout technology provides a more stable and permanent alteration, offering clear insights into the gene’s role over long experimental periods.
One of the unique selling points of our SIAH2 Gene Knockout Cell Lines is their high specificity and efficiency in gene alteration, ensuring that researchers can reliably assess the effects of SIAH2 depletion. These cell lines are rigorously validated, providing confidence in their reproducibility and accuracy when designing experiments. For researchers and clinicians aiming to deepen their understanding of cellular mechanics or develop targeted therapies, these models offer an unmatched opportunity.
Our company specializes in providing high-quality, precisely engineered biological products that empower scientific advancements in genetics and molecular biology. With an experienced team of researchers and a commitment to innovative technologies, we are dedicated to supporting the research community with our comprehensive suite of gene knockout cell lines and related products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.